Pharmaceutical Contract Manufacturing Market 2025 | Novo Holdings' $16.5B Catalent Deal, Samsung Biologics' $1.2B CMO Expansion, and GE Healthcare's €132M Ireland Investment Reshaping Global Supply Ch - News Summed Up

Pharmaceutical Contract Manufacturing Market 2025 | Novo Holdings' $16.5B Catalent Deal, Samsung Biologics' $1.2B CMO Expansion, and GE Healthcare's €132M Ireland Investment Reshaping Global Supply Ch


This acquisition is a blueprint for how future pharma giants will integrate R&D with robust supply chains. This move not only boosts their production capacity but also sets a new standard for CMO partnerships worldwide. This investment reinforces our long-term commitment to meeting the growing demand and strengthening our supply chain. "Eugene Barrett, Site Leader & Managing Director, GE Healthcare Ireland"The expansion of our Cork facility is a major milestone. This expansion will not only drive innovation but also create high-value jobs, strengthening Ireland's position as a leading hub for pharmaceutical manufacturing.


Source: The Times March 19, 2025 10:08 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */